Biological variation of procalcitonin in healthy individuals by A. Barassi et al.
Biological Variation of Procalcitonin in
Healthy Individuals
To the Editor
Procalcitonin (PCT) is a stable 116-
amino acid precursor molecule to the
hormone calcitonin. High serum con-
centrations have been reported in
patients with severe systemic bacte-
rial or fungal, but not viral, infections
(1 ).
Information on the biological vari-
ation of PCT is not available; this is
limiting because the clinical utility of
laboratory data can be affected by
physiologic variation (2 ). Here we
report the results of a study to deter-
mine the biological variation of PCT.
To investigate the biological varia-
tion of this analyte, we followed the
same protocol that we used for the
study of the biological variation of
N-terminal pro-B-type natriuretic
peptide (3 ). We took five blood spec-
imens from each of 16 apparently
healthy laboratory workers (5 men
and 11 women; age range, 43–62
years) twice a week (Tuesdays and
Fridays) over a 17-day period. None
of the workers smoked, took any
medication, or consumed substantial
quantities of alcohol. In accordance
with Helsinki Declaration II, the de-
sign and execution of the experiment
were explained thoroughly to the
participants, and informed consent
was obtained. Blood was collected
under standardized conditions to
minimize sources of preanalytic vari-
ation. After an overnight fast, a blood
specimen was taken by conventional
venipuncture between 0800 and 0900
with the volunteers in the sitting
position, avoiding venous stasis. All
samples were drawn by the same
phlebotomist, allowed to clot, and
then centrifuged at 3000g for 15 min
at room temperature within 1 h from
collection. Sera were separated and
stored at 70 °C until analysis.
At the end of the collection period,
all frozen samples were thawed,
mixed, and centrifuged for analysis
in a single run in duplicate. PCT
concentrations were determined by
the time-resolved amplified cryptate
emission (TRACE) methodology on
Kryptor (Brahms Diagnostic) by the
same analyst, who followed the as-
say manufacturer’s recommenda-
tions. The mean PCT concentrations
for men and women were not differ-
ent (P  0.93). The analytical (CVA)
and intra- (CVI) and interindividual
(CVG) components of variation were
calculated by nested ANOVA. The
reference change value (RCV) for sig-
nificant changes in serial results (P
0.05), the index of individuality,
and the desirable quality specifica-
tions for imprecision (I), bias (B), and
total error (TE) were calculated using
the following formulae:
RCV 21/2 1.96 (CVA2CVI2)1/2
I 0.5(CVI)
B 0.25(CVI2  CVG2)1/2
TE 1.65 I  B( 0.05).
The number of specimens that
should be collected to estimate (P
0.05) the homeostatic set point of
an individual within  10% [1.962 
(CVA
2  CVI
2)/100] was also evalu-
ated. The results are reported in Ta-
ble 1.
The TRACE precision assay does
not meet the goal [neither the desir-
able nor the minimum analytical pre-
cision, CVA 0.50(CVI) and CVA
0.75(CVI), respectively] based on
biological variation, at least at the
concentrations measured in our pop-
ulation. The error added to clinical
signal through analytical noise is
37% (2 ). Improvement is therefore
required if this assay is to be offered
on a routine basis. Finally, the low
index of individuality shows that the
use of population-based reference
limits is inadequate for interpretation.
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False-Negative Result in the
Detection of an IgM Monoclonal
Protein by Capillary Zone
Electrophoresis
To the Editor:
Capillary zone electrophoresis (CZE)
of serum proteins has developed
into a rapid and sensitive analytical
technique that is gaining impact in
clinical laboratories because of its
suitability for automation (1, 2). We
report a case of plasmacytic lym-
phoma with an IgM monoclonal
gammopathy that was difficult to
detect by CZE.
Table 1. Mean values; estimated mean analytical (CVA), intraindividual (CVI),
and interindividual (CVG) variation; and derived indices for serum PCT.
Group
Mean,
g/L
CVA,
%
CVI,
%
CVG,
% IIa
RCV,
% nb
Desirable quality
specifications
Imprecision,
%
Bias,
%
TE,
%
All 0.040 15 16 22 0.7 60.6 18 8.1 6.9 20.3
Men 0.043 14 19 21 0.9 65.5 21 9.4 7.1 22.6
Women 0.038 15 14 23 0.6 57.0 16 7.0 6.7 18.3
a II, index of individuality.
b Number of specimens that should be collected to estimate the homeostatic set point of an individual.
Letters
1878 Clinical Chemistry 50, No. 10, 2004
